CA2370298A1 - Peptide homodimers or peptide heterodimers derived from interleukin 12 - Google Patents

Peptide homodimers or peptide heterodimers derived from interleukin 12 Download PDF

Info

Publication number
CA2370298A1
CA2370298A1 CA002370298A CA2370298A CA2370298A1 CA 2370298 A1 CA2370298 A1 CA 2370298A1 CA 002370298 A CA002370298 A CA 002370298A CA 2370298 A CA2370298 A CA 2370298A CA 2370298 A1 CA2370298 A1 CA 2370298A1
Authority
CA
Canada
Prior art keywords
monomer
homodimer
heterodimer
monomers
interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002370298A
Other languages
English (en)
French (fr)
Inventor
Raimund J. Wieser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2370298A1 publication Critical patent/CA2370298A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002370298A 1999-04-27 2000-04-20 Peptide homodimers or peptide heterodimers derived from interleukin 12 Abandoned CA2370298A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19919148A DE19919148A1 (de) 1999-04-27 1999-04-27 Von Interleukin 12 abgeleitete Peptid-Homodimere und Peptid-Heterodimere
DE19919148.4 1999-04-27
PCT/DE2000/001260 WO2000064938A2 (de) 1999-04-27 2000-04-20 Von interleukin 12 abgeleitete peptid-homodimere und peptid-heterodimere

Publications (1)

Publication Number Publication Date
CA2370298A1 true CA2370298A1 (en) 2000-11-02

Family

ID=7906047

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002370298A Abandoned CA2370298A1 (en) 1999-04-27 2000-04-20 Peptide homodimers or peptide heterodimers derived from interleukin 12

Country Status (6)

Country Link
EP (1) EP1171464A2 (de)
JP (1) JP2002543091A (de)
AU (1) AU5388600A (de)
CA (1) CA2370298A1 (de)
DE (1) DE19919148A1 (de)
WO (1) WO2000064938A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010503687A (ja) * 2006-09-15 2010-02-04 ザ バーナム インスティチュート 高親和性ＥｐｈＢ受容体結合化合物とその使用法
AU2012228769B2 (en) * 2011-03-14 2016-09-08 Phlogo Aps Antagonists of the interleukin- 1 receptor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2125763C (en) * 1993-07-02 2007-08-28 Maurice Kent Gately P40 homodimer of interleukin-12
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12

Also Published As

Publication number Publication date
DE19919148A1 (de) 2000-11-16
JP2002543091A (ja) 2002-12-17
WO2000064938A3 (de) 2001-04-12
EP1171464A2 (de) 2002-01-16
AU5388600A (en) 2000-11-10
WO2000064938A2 (de) 2000-11-02

Similar Documents

Publication Publication Date Title
EP0412486B1 (de) Antikörper gegen TNF-Bindungsprotein I und deren F(ab)-Fragmente
US5270171A (en) Cancer-associated SCM-recognition factor, preparation and method of use
Smith et al. Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics.
US5985280A (en) Diagnosis and/or therapy of tumours using monoclonal antibodies specific for the human IL-4 receptor
US5359037A (en) Antibodies to TNF binding protein I
JP3541296B2 (ja) 腫瘍血管内皮細胞に特異的に結合するモノクローナル抗体とその利用方法
US4002740A (en) Tridecapeptide compositions and methods
US6699973B1 (en) Antibodies to peptides that target GIT receptors and related methods
JPH05213775A (ja) Ｂｆａ抗体
US20040115206A1 (en) Antibody-mediated induction of tumor cell death
US5721211A (en) Compositions and methods for treating small cell and nonsmall cell lung cancers
JP3104187B2 (ja) インターフエロン―ガンマ結合蛋白
CA2370298A1 (en) Peptide homodimers or peptide heterodimers derived from interleukin 12
US9884918B2 (en) HER2DELTA16 peptides
Johnson et al. Identification of an antigenic epitope and receptor binding domain of human C5a.
Hashim et al. Experimental allergic encephalomyelitis: Basic protein regions responsible for delayed hypersensitivity
Crary et al. Role of a basement membrane glycoprotein in anti-tubular basement membrane nephritis
EP1009431A1 (de) Antikörper gegen den menschlichen tumornekrosefaktor-rezeptor des typs 2 (tr2)
CA2371662A1 (en) Peptide homodimers and peptide heterodimers, derived from interferon .alpha.2
JP2717319B2 (ja) Ｒ―ｉｆｎ―ベータエピトープ部位を代表するペプチド、それに対する抗体、およびその用途
Makker et al. Renal antigens in mercuric chloride induced, anti-GBM autoantibody glomerular disease
PT100568A (pt) Anticorpos monoclonais e antigeneos para o melanoma humano
Inagaki et al. A new sandwich enzyme-linked immunosorbent assay (ELISA) for tranforming growth factor α (TGFα) based upon conformational modification by antibody binding
WO1991003251A1 (en) Cr2 ligand compositions and methods for modulating immune cell functions
WO1994025483A1 (en) Immunotherapeutic peptides derived from toxic shock syndrome toxin-1, antibodies thereto, their uses in pharmaceutical compositions and diagnosis

Legal Events

Date Code Title Description
FZDE Dead